Researchers at The University of Texas MD Anderson Cancer Center were able to eradicate measurable residual disease (MRD) in ...

Emerging discoveries in liquid biomarker research promise to transform the early detection, diagnosis and treatment ...

An investigational targeted therapy designed to block one of the most common genetic drivers of pancreatic cancer has shown ...

A blood test may help identify which patients with colorectal cancer that has spread to the liver are most likely to benefit from chemotherapy after surgery, according to research presented today at ...

A London clinic owner has claimed he is treating people with stage 4 cancer by sealing them into a plastic bag while they're naked from the waist down and gassing them with chlorine dioxide.

Health Canada is asking consumers to check their homes for a potentially dangerous household deodorizer. A product recall notice has been issued for “Safrax ODOR-CLO2 Chlorine Dioxide Odor Removal — ...

A medical breakthrough in the fight against pancreatic cancer is showing promising results after decades of research. The experimental drug, taken once a day, extends patients’ lives by slowing the ...

A new, experimental medication nearly doubled overall survival rates for patients with advanced pancreatic cancer, according to the results of a study published Sunday. Researchers say the findings ...

Every single patient with advanced pancreatic cancer who walked into Dr. Zev Wainberg’s office told him they would rather take an experimental medication than endure another round of chemotherapy.

An experimental pancreatic cancer drug that’s been shown to double survival in patients with advanced stages of the disease is poised to revolutionize the way the cancer is treated, oncologists say.

In separate clinical trials, two treatments showed promise that they could help patients with one of the most dire diagnoses in oncology. By Rebecca Robbins and Gina Kolata Two treatments being tested ...

New clinical trial data show KRAS-blocking drugs may significantly improve survival for the disease. “I think this is truly an earth-shattering moment in pancreatic cancer.” Daraxonrasib, an ...